SEP 19, 2017 09:17 AM PDT
Bacteria contribute to chemotherapy resistance
WRITTEN BY: Kerry Evans
2 8 530

Bacteria in tumors make cancer resistant to chemotherapy. Wait, what? That’s right. According to Ravid Straussman at the Weizmann Institute, Gammaproteobacteria inside of pancreatic tumors metabolize the chemotherapy drug gemcitabine into its inactive form. Gemcitabine is a nucleoside analog that is commonly used to treat pancreatic cancer, as well as breast, bladder, and lung cancers.

 

Bacteria can make tumors resistant to chemotherapy

Image: Mesothelioma Clinic

Hold up - bacteria in tumors? Yes, evidently that’s a thing, and I’ll take their word for it (for now). Initially, Straussman and his colleagues observed that conditioned medium from human dermal fibroblasts made colorectal and pancreatic cancer cells resistant to gemcitabine. When they filtered the medium, however, it no longer conferred resistance. Thus, they hypothesized that something bacteria-sized made the cancer cells resistant to gemcitabine.

They sequenced the conditioned medium and found DNA from Mycoplasma (mostly Mycoplasma hyorhinis). Further, when they treated the medium with an antibiotic, it no longer made cancer cells resistant to gemcitabine. One possibility was that gemcitabine was being modified in some way. Thus, they used high-performance liquid chromatography-tandem mass spectrometry to show that, indeed, the bacteria metabolized gemcitabine into its inactive form. Notably, Mycoplasma isn’t the only bacterium that can modify gemcitabine; 13 of 27 other species they tested did so as well.

Next, they wanted to know wanted to know which Mycoplasma genes were required to metabolize gemcitabine. Actually, they knew that the bacterial enzyme cytidine deaminase (CDD) was able to modify gemcitabine, so they investigated this gene first. Of the 27 bacterial species they tested previously, all of the ones that expressed the long form of CDD (CDDL) conferred gemcitabine resistance. None of the species that lacked CDD conferred resistance, but one that expressed the short form of CDD did.

To confirm that CDDL conferred gemcitabine resistance, they deleted CDDL from E. coli and showed that these bacteria could not metabolize gemcitabine. As expected, restoring CDDL activity to E. coli also restored the ability to metabolize gemcitabine.

Finally, the researchers validated their findings in an animal model. They injected colon tumor-bearing mice with a strain of E. coli that colonizes tumors and produces CDDL. They also tagged the bacteria and tumor cells with different fluorescent tags, allowing them to image each cell type in vivo. Then, they treated mice with gemcitabine with or without an antibiotic to kill the CDDL-producing E. coli. Bacteria were not detected in the antibiotic-treated mice, and these mice showed an antitumor response with gemcitabine. In the mice that weren’t treated with antibiotics, however, gemcitabine had no effect on tumor growth.

Sources: Science and Weizmann Institute

 

About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
APR 30, 2018
Clinical & Molecular DX
APR 30, 2018
Reducing Dependency on Antibiotics in Hospitals
How can small community and rural hospitals create antibiotic stewardship programs to reduce the danger of antibiotic resistance? Scientists from the Inter
MAY 02, 2018
Immunology
MAY 02, 2018
Photographing the Measles Virus
The measles virus was caught leaving infected cells by the scientific paparazzi, that is, experts from Emory Health Sciences using cryo-electron tomography
MAY 17, 2018
Microbiology
MAY 17, 2018
Increased Concern as Ebola Outbreak Spreads to a City
Along with partners like Médecins Sans Frontières, WHO is springing into action to try to stop the spread of the virus.
MAY 21, 2018
Microbiology
MAY 21, 2018
Common Antibacterial Chemical may Help Fight Lung Infections
New research has found when triclosan is used with another FDA-approved drug, it can help fight deadly illness.
MAY 22, 2018
Cancer
MAY 22, 2018
Breakthrough Analysis Outlines Conceivable Cause of Childhood ALL
A team from the Institute of Cancer Research has published a comprehensive literature review and outlined a breakthrough in the causative theory of childhood ALL development.
JUN 08, 2018
Clinical & Molecular DX
JUN 08, 2018
Early Detection of Tooth Decay from Bacterial Invasion
We all get cavities, but have we ever thought much about the biology of the process? From the Akson Russian Science Communication Association, scientists i
Loading Comments...